Literature DB >> 11181835

IPF, a vesicular uptake inhibitory protein factor, can reduce the Ca(2+)-dependent, evoked release of glutamate, GABA and serotonin.

Y Tamura1, E D Ozkan, D G Bole, T Ueda.   

Abstract

Synaptic vesicles in the nerve terminal play a pivotal role in neurotransmission. Neurotransmitter accumulation into synaptic vesicles is catalyzed by distinct vesicular transporters, harnessing an electrochemical proton gradient generated by V-type proton-pump ATPase. However, little is known about regulation of the transmitter pool size, particularly in regard to amino acid neurotransmitters. We previously provided evidence for the existence of a potent endogenous inhibitory protein factor (IPF), which causes reduction of glutamate and GABA accumulation into isolated, purified synaptic vesicles. In this study we demonstrate that IPF is concentrated most in the synaptosomal cytosol fraction and that, when introduced into the synaptosome, it leads to a decrease in calcium-dependent exocytotic (but not calcium-independent) release of glutamate in a concentration-dependent manner. In contrast, alpha-fodrin (non-erythroid spectrin), which is structurally related to IPF and thought to serve as the precursor for IPF, is devoid of such inhibitory activity. Intrasynaptosomal IPF also caused reduction in exocytotic release of GABA and the monoamine neurotransmitter serotonin. Whether IPF affects vesicular storage of multiple neurotransmitters in vivo would depend upon the localization of IPF. These results raise the possibility that IPF may modulate synaptic transmission by acting as a quantal size regulator of one or more neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181835     DOI: 10.1046/j.1471-4159.2001.00120.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Glutamate Release.

Authors:  John T Hackett; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2015-05-27       Impact factor: 3.996

3.  A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow.

Authors:  Yutaka Tamura; Kiyokazu Ogita; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2013-11-19       Impact factor: 3.996

Review 4.  Presynaptic Molecular Determinants of Quantal Size.

Authors:  Shigeo Takamori
Journal:  Front Synaptic Neurosci       Date:  2016-02-08

5.  Cryoloading: introducing large molecules into live synaptosomes.

Authors:  Arup R Nath; Robert H C Chen; Elise F Stanley
Journal:  Front Cell Neurosci       Date:  2014-01-23       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.